• David Royston and R Peter Alston.
• Department of Cardiothoracic Anaesthesia, Critical Care and Pain Management, Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital Harefield, Uxbridge, United Kingdom. Electronic address: d.royston@rbht.nhs.uk.
• J. Cardiothorac. Vasc. Anesth. 2021 Dec 1; 35 (12): 3746-3759.

AbstractThis review is intended to highlight some of the historic events that contributed to the development of thoracic and cardiac anesthesia and surgery in Great Britain and Northern Ireland (UK). The aim of this first of two parts is to concentrate on the development of techniques, facilities, and pharmacology that allowed progress and advancement in patient management that were developed primarily in the UK. However, progress usually requires input from a wide variety of sources of knowledge, and cardiothoracic practice is no exception. Reference is, thus, made to sources outside of the UK that guided, influenced, or inspired changes in practice, such as the techniques of operating on the heart and great vessels in war casualties, developed by Dr. Dwight Harken, or the demonstration of the Blalock-Thomas-Taussig shunt by Alfred Blalock. In addition to advances in medical equipment, such as computed tomography, the UK contributed greatly to pharmacologic interventions that were unique at the time in such varied areas as nonflammable volatile anesthetic agents, heart failure treatments, and neuromuscular blocking agents for both cardiac and thoracic surgical practice.Crown Copyright © 2021. Published by Elsevier Inc. All rights reserved.

13 keywords...

hide…